EE466 Implementing the Generalized Risk-Adjusted Cost-Effectiveness (GRACE) Model for Sickle-Cell Disease: A Case Study
Jun 1, 2024, 00:00
10.1016/j.jval.2024.03.761
https://www.valueinhealthjournal.com/article/S1098-3015(24)00876-3/fulltext
Title :
EE466 Implementing the Generalized Risk-Adjusted Cost-Effectiveness (GRACE) Model for Sickle-Cell Disease: A Case Study
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(24)00876-3&doi=10.1016/j.jval.2024.03.761
First page :
Section Title :
Open access? :
No
Section Order :
10229